HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group.

Authors
JournalEuropean journal of cancer (Eur J Cancer (1965)) Vol. 14 Issue 8 Pg. 851-6 (Aug 1978) ISSN: 0014-2964 [Print] England
PMID357162 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Nitrosourea Compounds
  • Lomustine
Topics
  • Brain Neoplasms (drug therapy, mortality)
  • Clinical Trials as Topic
  • Female
  • Glioma (drug therapy, mortality)
  • Humans
  • Lomustine (therapeutic use)
  • Male
  • Neoplasm Recurrence, Local
  • Nitrosourea Compounds (therapeutic use)
  • Prognosis
  • Random Allocation
  • Remission, Spontaneous
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: